Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of MP-376 (levofloxacin) in cystic fibrosis patients with Pseudomonas aeruginosa infection
2008-001728-30Phase 2Completed
- Sponsor
- Mpex Pharmaceuticals, Inc.
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levofloxacin in cystic fibrosis (CF) and Pseudomonal infection (4 arms), sponsored by Mpex Pharmaceuticals, Inc. Started May 2008; status: completed.
02
Drugs
levofloxacin
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on 2008-001728-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001728-30.